Zenosense Inc. s primary focus, through our joint venture ownership in MIDS Medical Ltd., is the development of a cost effective, hand held Point of Care rapid cardiac diagnostic device, MIDS Cardiac. MIDS Medical Ltd. applies patent protected magnetic nanoparticle detection technology and a development team with world class technical expertise. The MIDS Cardiac device and test strip is being designed to support a variety of rapid high sensitivity cardiac biomarker tests, with a focus on troponin I and T, to identify or discount Acute Myocardial Infarction with accuracy equal or superior to high sensitivity assays performed on laboratory analyzers.
Quote | Zenosense Inc (OTCMKTS:ZENO)
Last: | $0.0009 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0009 |
High: | $0 |
Low: | $0 |
Volume: | 0 |
Last Trade Date Time: | 09/22/2023 03:00:00 am |
News | Zenosense Inc (OTCMKTS:ZENO)
NEW YORK , June 5, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective OTCQX® and OTCQB® markets and Caveat Emptor Desig...
VALENCIA, SPAIN, March 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held technology for the early detection o...
Message Board Posts | Zenosense Inc (OTCMKTS:ZENO)
Subject | By | Source | When |
---|---|---|---|
Hahaha good one. I agree! | Mbrady4 | investorshub | 11/01/2022 12:37:56 AM |
my investment here made zerosense | aljafy | investorshub | 10/31/2022 1:27:31 AM |
Condolences to all! Heartbreaking! | nickjackson600 | investorshub | 10/30/2022 2:13:53 AM |
Anyone have any info on this turd? | Mbrady4 | investorshub | 10/07/2022 1:52:35 PM |
the fat lady has sung. i forget why | aljafy | investorshub | 09/13/2022 2:17:13 AM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK , June 5, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective OTCQX® and OTCQB® markets and Caveat Emptor Desig...
VALENCIA, SPAIN, March 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held technology for the early detection o...
Agreement signed with third party investor to fund up to $1.2 million to support next crucial development phase of MIDS Cardiac POC diagnostic device Patented MIDS technology has successfully detected commercial assay beads at a level approximately four times better than the threshold adv...